Obesity risks: Towards an emerging Inuit pattern

International Journal of Circumpolar Health

Volumn 70, Issue 2, 2011, Pages 166-177

  Château Degat, Marie Ludivine ^a,b   Dewailly, Eric ^b   Charbonneau, Guylaine ^a,b   Laouan Sidi, Elhadji A ^b   Tremblay, Angelo ^c   Egeland, Grace M ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Anthropometry; Body mass index; Cormic Index; Inuit; Obesity; Sitting height

Indexed keywords

EID: 79955822517     PISSN: 12399744     EISSN: None     Source Type: Journal    
DOI: 10.3402/ijch.v70i2.17802     Document Type: Article

References (48)

1. Bjerregaard P. Contribution of population surveys to the study of cardiovascular disease and diabetes in Greenland. Int J Circumpolar Health 2003;62(4):331-342.
2. Naylor JL, Schraer CD, Mayer AM, Lanier AP, Treat CA, Murphy NJ. Diabetes among Alaska Natives: a review. Int J Circumpolar Health 2003;62(4):363-387.
3. Young TK, Reading J, Elias B, O'Neil JD. Type 2 diabetes mellitus in Canada's First Nations: status of an epidemic in progress. CMAJ 2000;163(5):561-566.
4. Young TK. Sociocultural and behavioural determinants of obesity among Inuit in the central Canadian Arctic. Soc Sci Med1996;43(11):1665-1671.
5. Jorgensen ME, Glumer C, Bjerregaard P, Gyntelberg F, Jorgensen T, Borch-Johnsen K. Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): relationship to metabolic risk factors. Int J Obes Relat Metab Disord 2003;27(12):1507-1515.
6. Charbonneau-Roberts G, Young TK, Egeland GM. Inuit anthropometry and insulin resistance. Int J Circumpolar Health 2007;66(2):129-134.
7. Demirjian A. Anthropometry Report. Height, Weight, and Body Dimensions: A Report from Nutrition Canada. Ottawa: Minister of National Health and Welfare, Health and Promotion Directorate, Health Services and Promotion Branch; 1980. 133 p.
8. Szathmary E. Human biology of the Arctic. In: DD A, editor. Handbook of North American Indians. Washington, DC: Smithsonian Institution; 1984. p. 64-71.
9. Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D'Agostino RB. Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006;91(8):2906-2912.
10. Charbonneau-Roberts G, Saudny-Unterberger H, Kuhnlein HV, Egeland GM. Body mass index may overestimate the prevalence of overweight and obesity among the Inuit. Int J Circumpolar Health 2005;64(2):163-169.
11. Gallagher D, Heymsfield SB, Heo M, Jebb SA, Murgatroyd PR, Sakamoto Y. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index. Am J Clin Nutr 2000;72(3):694-701.
12. Norgan NG. Population differences in body composition in relation to the body mass index. Eur J Clin Nutr 1994;48(Suppl 3):S10-25; discussion S6-7.
13. Norgan NG. Relative sitting height and the interpretation of the body mass index. Ann Hum Biol 1994;21(1):79-82.
14. Norgan NG, Jones PR. The effect of standardising the body mass index for relative sitting height. Int J Obes Relat Metab Disord 1995;19(3):206-208.
15. Collins S, Duffield A, Myatt M. Assessment of Nutritional Status in Emergency-Affected Populations-Adults. Geneva: UN ACC/Sub-Committee on Nutrition; 2000. Available from: http://www.unsystem.org/scn/archives/adults/index.htm.
16. Health Canada. Canadian guidelines for body weight classification in adults. Ottawa: Health Canada; 2003. 41 p.
17. World Health Organisation. Obesity and Overweight. Insert City: WHO International; 2006 [cited 2009 Aug 18]; Available from: http://www.who.int/mediacentre/factsheets/fs311/en/index.html.
18. Abbott D, Campbell N, Carruthers-Czyzewski P, Chockalingam A, David M, Dunkley G, et al. Guidelines for measurement of blood pressure, follow-up, and lifestyle counselling. Canadian Coalition for High Blood Pressure Prevention and Control. Can J Public Health 1994;85(Suppl 2):S29-43.
19. World Health Organization. 1999 World Health Organization-International Society of Hypertension guidelines for the management of hypertension. Guidelines Subcommittee. J Hypertens 1999;17(2):151-183.
20. Chateau-Degat ML, Dewailly E, Louchini R, Counil E, Noel M, Ferland A, et al. Cardiovascular burden and related risk factors among Nunavik (Quebec) Inuit: insights from baseline findings in the circumpolar Inuit health in transition cohort study. Can J Cardiol 2010;26(6):190-196.
21. Tremblay AJ, Morrissette H, Gagne JM, Bergeron J, Gagne C, Couture P. Validation of the Friedewald formula for the determination of low-density lipoprotein cholesterol compared with beta-quantification in a large population. Clin Biochem 2004;37(9):785-790.
22. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28(7):412-419.
23. Dewailly E, Dallaire R, Pereg D, Ayotte P, Fontaine J, Dery S. Exposure to environemental contaminants in Nunavik: persistent organic pollutents and new contaminants of concern. Québec: Institut national de santé publique du Québec (INSPQ) & Nunavik Regional Board of Health and Social Services (NRBHSS); 2007. 13 p.
24. Colin L, editor. Introduction to quantile regression and QUANTREG procedure. 30th SAS user group international conference. Philadelphia: SAS institute INC; 2005.
25. Fisher LD, Van Belle G. Categorical data:contingency tables. In: Barnett VBR, Fisher NI, Hunter JS, Kadane JB, Kendall DG, et al., editors. Biostatistics: a methodology for health sciences. New York: John Wiley and Sons; 1993. p. 246-301.
26. Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. 2008 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2008;32(Suppl 1):S1-215.
27. Meigs JB, Jacques PF, Selhub J, Singer DE, Nathan DM, Rifai N, et al. Fasting plasma homocysteine levels in the insulin resistance syndrome: the Framingham offspring study. Diabetes Care 2001;24(8):1403-1410.
28. Genest J, McPherson R, Frohlich J, Anderson T, Campbell N, Carpentier A, et al. 2009 Canadian Cardiovascular Society/ Canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can J Cardiol 2009;25(10):567-579.
29. Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/ National Heart, Lung, and Blood Institute scientific statement. Circulation 2005;112(17):2735-2752.
30. McPherson R, Frohlich J, Fodor G, Genest J, Canadian Cardiovascular Society. Canadian Cardiovascular Society position statement-recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease. Can J Cardiol 2006;22(11):913-927.
31. World Health Organisation. Redefining obesity and its treatment: The Asia-Pacific Perspective. Manila: World Health Organization, Regional Office for the Western Pacific; 2000. 55 p.
32. Tjepkema M, Shields M. Measured obesity: adult obesity in Canada. Ottawa: Statistics Canada; 2005. 32 p.
33. Wooldridge JM. Introductory econometrics: a modern approach. Mason, OH: South-Western; 2009. 912 p.
34. Belanger-Ducharme F, Tremblay A. Prevalence of obesity in Canada. Obes Rev 2005;6(3):183-186.
35. Lee K, Song YM, Sung J. Which obesity indicators are better predictors of metabolic risk?: healthy twin study. Obesity (Silver Spring) 2008;16(4):834-840.
36. Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, et al. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005;366(9497):1640-1649.
37. Deurenberg P, Yap M, van Staveren WA. Body mass index and percent body fat: a meta analysis among different ethnic groups. Int J Obes Relat Metab Disord 1998;22(12):1164-1171.
38. Balkau B, Deanfield JE, Despres JP, Bassand JP, Fox KA, Smith SC Jr., et al. International Day for the Evaluation of Abdominal Obesity (IDEA): a study of waist circumference, cardiovascular disease, and diabetes mellitus in 168,000 primary care patients in 63 countries. Circulation 2007;116(17):1942-1951.
39. Pouliot MC, Despres JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73(7):460-468.
40. Wang Y, Wang QJ. The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem. Arch Intern Med 2004;164(19):2126-2134.
41. Schumacher C, Ferucci ED, Lanier AP, Slattery ML, Schraer CD, Raymer TW, et al. Metabolic syndrome: prevalence among American Indian and Alaska native people living in the southwestern United States and in Alaska. Metab Syndr Relat Disord 2008;6(4):267-273.
42. Chateau-Degat M, Pereg D, Egeland GM, Nieboer E, Bonnier-Viger Y, Laouan-Sidi Elhadji A, et al. Diabetes and related metabolic conditions in an aboriginal Cree community of Quebec, Canada. Can J Diabetes 2009;33(3):156-162.
43. Young TK. Obesity, central fat patterning, and their metabolic correlates among the Inuit of the central Canadian Arctic. Hum Biol 1996;68(2):245-263.
44. Chateau-Degat ML, Dewailly E, Poirier P, Gingras S, Egeland GM. Comparison of diagnostic criteria of the metabolic syndrome in 3 ethnic groups of Canada. Metabolism 2008;57(11):1526-1532.
45. Utzschneider KM, Van de Lagemaat A, Faulenbach MV, Goedecke JH, Carr DB, Boyko EJ, et al. Insulin resistance is the best predictor of the metabolic syndrome in subjects with a first-degree relative with type 2 diabetes. Obesity (Silver Spring) 2010;18(9):1781-1787.
46. Karelis AD. Metabolically healthy but obese individuals. Lancet 2008;372(9646):1281-1283.
47. Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, et al. The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med 2008;168(15):1617-1624.
48. Karelis AD, Brochu M, Rabasa-Lhoret R. Can we identify metabolically healthy but obese individuals (MHO)? Diabetes Metab 2004;30(6):569-572.